A next-generation COVID-19 mucosal vaccine is set to be a gamechanger not only when delivering the vaccine itself, but also for people who are needle-phobic.
Griffith University researchers have developed a potential vaccine for a pathogen causing severe infection in immunocompromised people.
As Streptococcus A cases continue to be prevalent in Queensland and internationally, a new nasal vaccine could provide long-term protection from the deadly bacteria.
Hope is on the horizon for needle-phobic patients as Griffith University researchers have created a new influenza vaccine composition designed to be administered via the nose.
Griffith University Institute for Glycomics researchers are closer to the development of a new vaccine aimed at preventing the deadly Streptococcus A (Strep A), which kills more than 500,000 people globally per year.
Is man flu real? Is there a valid biological reason behind men’s symptoms or are men just malingering? And how does man flu differ from flu? Professor Thea van de Martel explains.
Nine new Griffith-led ARC Discovery Projects awarded $3,622,738.
A bacterium commonly present in the nose can sneak into the brain and may increase the risk of Alzheimer’s disease.
